カテゴリー： LP Information, 世界, 医療/バイオ

EEG/EMG/誘発電位検査装置のグローバル市場予測2023-2029

◆英語タイトル：Global EEG, EMG and Evoked Potential Devices Market Growth 2023-2029

LP Informationが発行した調査報告書（LP23MY4607）◆商品コード：LP23MY4607
◆発行会社（リサーチ会社）：LP Information
◆発行日：2023年5月（※2025年版があります。お問い合わせください。）
◆ページ数：100
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥527,040見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥790,560見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,054,080見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LP Informationの最新刊調査レポート「EEG/EMG/誘発電位検査装置のグローバル市場」は、過去の販売実績から2022年の世界のEEG/EMG/誘発電位検査装置の総販売量を検討し、2023年から2029年の予測されるEEG/EMG/誘発電位検査装置の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のEEG/EMG/誘発電位検査装置の市場規模を掲載し、XXX百万米ドル規模の世界のEEG/EMG/誘発電位検査装置市場の詳細な分析を提供します。本インサイトレポートは、世界のEEG/EMG/誘発電位検査装置業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のEEG/EMG/誘発電位検査装置市場における各社の独自のポジションをより深く理解するために、EEG/EMG/誘発電位検査装置製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のEEG/EMG/誘発電位検査装置市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。EEG/EMG/誘発電位検査装置の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。EEG/EMG/誘発電位検査装置の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。EEG/EMG/誘発電位検査装置のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

EEG/EMG/誘発電位検査装置の世界主要メーカーとしては、Cadwell Laboratories(US)、 Compumedics Limited (Australia)、 EB Neuro S.P.A. (Italy)、 Electrical Geodesics(US)、 Lifelines Neurodiagnostic Systems(US)、 Natus Medical Incorporated (US)、 NeuroWave Systems(US)、 Nihon Kohden Corporation (Japan)、 Nihon Kohden America(US)、 Noraxon USA.(US)などを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のEEG/EMG/誘発電位検査装置市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場セグメンテーション】

この調査ではEEG/EMG/誘発電位検査装置市場をセグメンテーションし、種類別 (脳波検査（EEG）、筋電図検査（EMG）、誘発電位)、用途別 (感染症、頭部外傷、昏睡・脳死、代謝障害、脳血管障害)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：脳波検査（EEG）、筋電図検査（EMG）、誘発電位

・用途別区分：感染症、頭部外傷、昏睡・脳死、代謝障害、脳血管障害

・地域別区分
南北アメリカ（米国、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のEEG/EMG/誘発電位検査装置市場の10年間の市場状況・展望は？
・世界および地域別に見たEEG/EMG/誘発電位検査装置市場成長の要因は何か？
・EEG/EMG/誘発電位検査装置の市場機会はエンドマーケットの規模によってどのように変化するのか？
・EEG/EMG/誘発電位検査装置のタイプ別、用途別の内訳は？
・新型コロナウイルスとロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：EEG/EMG/誘発電位検査装置の年間販売量2018-2029、地域別現状・将来分析
・EEG/EMG/誘発電位検査装置の種類別セグメント：脳波検査（EEG）、筋電図検査（EMG）、誘発電位
・EEG/EMG/誘発電位検査装置の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・EEG/EMG/誘発電位検査装置の用途別セグメント：感染症、頭部外傷、昏睡・脳死、代謝障害、脳血管障害
・EEG/EMG/誘発電位検査装置の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のEEG/EMG/誘発電位検査装置市場
・企業別のグローバルEEG/EMG/誘発電位検査装置市場データ：2018-2023年の年間販売量、市場シェア
・企業別のEEG/EMG/誘発電位検査装置の年間売上：2018-2023年の売上、市場シェア
・企業別のEEG/EMG/誘発電位検査装置販売価格
・主要企業のEEG/EMG/誘発電位検査装置生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

EEG/EMG/誘発電位検査装置の地域別レビュー
・地域別のEEG/EMG/誘発電位検査装置市場規模2018-2023：年間販売量、売上
・主要国別のEEG/EMG/誘発電位検査装置市場規模2018-2023：年間販売量、売上
・南北アメリカのEEG/EMG/誘発電位検査装置販売の成長
・アジア太平洋のEEG/EMG/誘発電位検査装置販売の成長
・ヨーロッパのEEG/EMG/誘発電位検査装置販売の成長
・中東・アフリカのEEG/EMG/誘発電位検査装置販売の成長

南北アメリカ市場
・南北アメリカの国別のEEG/EMG/誘発電位検査装置販売量、売上（2018-2023）
・南北アメリカのEEG/EMG/誘発電位検査装置の種類別販売量
・南北アメリカのEEG/EMG/誘発電位検査装置の用途別販売量
・米国市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のEEG/EMG/誘発電位検査装置販売量、売上（2018-2023）
・アジア太平洋のEEG/EMG/誘発電位検査装置の種類別販売量
・アジア太平洋のEEG/EMG/誘発電位検査装置の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のEEG/EMG/誘発電位検査装置販売量、売上（2018-2023）
・ヨーロッパのEEG/EMG/誘発電位検査装置の種類別販売量
・ヨーロッパのEEG/EMG/誘発電位検査装置の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のEEG/EMG/誘発電位検査装置販売量、売上（2018-2023）
・中東・アフリカのEEG/EMG/誘発電位検査装置の種類別販売量
・中東・アフリカのEEG/EMG/誘発電位検査装置の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・EEG/EMG/誘発電位検査装置の製造コスト構造分析
・EEG/EMG/誘発電位検査装置の製造プロセス分析
・EEG/EMG/誘発電位検査装置の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・EEG/EMG/誘発電位検査装置の主要なグローバル販売業者
・EEG/EMG/誘発電位検査装置の主要なグローバル顧客

地域別のEEG/EMG/誘発電位検査装置市場予測レビュー
・地域別のEEG/EMG/誘発電位検査装置市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・EEG/EMG/誘発電位検査装置の種類別市場規模予測
・EEG/EMG/誘発電位検査装置の用途別市場規模予測

主要企業分析
Cadwell Laboratories(US)、 Compumedics Limited (Australia)、 EB Neuro S.P.A. (Italy)、 Electrical Geodesics(US)、 Lifelines Neurodiagnostic Systems(US)、 Natus Medical Incorporated (US)、 NeuroWave Systems(US)、 Nihon Kohden Corporation (Japan)、 Nihon Kohden America(US)、 Noraxon USA.(US)
・企業情報
・EEG/EMG/誘発電位検査装置製品
・EEG/EMG/誘発電位検査装置販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Electroencephalogram (EEG) is used to diagnose brain disorders and visualizes the activity of the brain during a seizure. EEG evaluates people who are suffering from brain problems such as coma, confusions and tumors, difficulties in thinking and memory and weakening of specific parts of the body. Electromyography (EMG) measures the electrical activity of muscles at the time of rest and contraction. An EMG uses tiny devices called electrodes which help in transmission and detection of electrical signals. Evoked Potential devices are used to clinically diagnose a wide variety of central nervous system (CNS) diseases.
LPI (LP Information)’ newest research report, the “EEG, EMG and Evoked Potential Devices Industry Forecast” looks at past sales and reviews total world EEG, EMG and Evoked Potential Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected EEG, EMG and Evoked Potential Devices sales for 2023 through 2029. With EEG, EMG and Evoked Potential Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world EEG, EMG and Evoked Potential Devices industry.
This Insight Report provides a comprehensive analysis of the global EEG, EMG and Evoked Potential Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on EEG, EMG and Evoked Potential Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global EEG, EMG and Evoked Potential Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for EEG, EMG and Evoked Potential Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global EEG, EMG and Evoked Potential Devices.
The global EEG, EMG and Evoked Potential Devices market size is projected to grow from US$ 1138.4 million in 2022 to US$ 1572.2 million in 2029; it is expected to grow at a CAGR of 1572.2 from 2023 to 2029.
In Europe, Germany, Italy, the U.K. and France holds major share of EEG, EMG and Evoked Potential devices market. However, Asia is expected to show high growth rates in the next five years in global EEG, EMG and Evoked Potential devices market. This is due to many companies constructing their R&D facilities in the region. In addition, increasing awareness about various neurological diseases is also supporting in the growth of EEG, EMG and Evoked Potential devices market in the region. Japan, China and India are expected to be the fastest growing EEG, EMG and Evoked Potential devices markets in Asia.
This report presents a comprehensive overview, market shares, and growth opportunities of EEG, EMG and Evoked Potential Devices market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Electroencephalography (EEG)
Electromyography (EMG)
Evoked Potential
Segmentation by application
Infections
Head Injuries
Coma and Brain Death
Metabolic Disorders
Cerebrovascular Disorders
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Cadwell Laboratories(US)
Compumedics Limited (Australia)
EB Neuro S.P.A. (Italy)
Electrical Geodesics(US)
Lifelines Neurodiagnostic Systems(US)
Natus Medical Incorporated (US)
NeuroWave Systems(US)
Nihon Kohden Corporation (Japan)
Nihon Kohden America(US)
Noraxon USA.(US)
Key Questions Addressed in this Report
What is the 10-year outlook for the global EEG, EMG and Evoked Potential Devices market?
What factors are driving EEG, EMG and Evoked Potential Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do EEG, EMG and Evoked Potential Devices market opportunities vary by end market size?
How does EEG, EMG and Evoked Potential Devices break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global EEG, EMG and Evoked Potential Devices Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for EEG, EMG and Evoked Potential Devices by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for EEG, EMG and Evoked Potential Devices by Country/Region, 2018, 2022 & 2029
2.2 EEG, EMG and Evoked Potential Devices Segment by Type
2.2.1 Electroencephalography (EEG)
2.2.2 Electromyography (EMG)
2.2.3 Evoked Potential
2.3 EEG, EMG and Evoked Potential Devices Sales by Type
2.3.1 Global EEG, EMG and Evoked Potential Devices Sales Market Share by Type (2018-2023)
2.3.2 Global EEG, EMG and Evoked Potential Devices Revenue and Market Share by Type (2018-2023)
2.3.3 Global EEG, EMG and Evoked Potential Devices Sale Price by Type (2018-2023)
2.4 EEG, EMG and Evoked Potential Devices Segment by Application
2.4.1 Infections
2.4.2 Head Injuries
2.4.3 Coma and Brain Death
2.4.4 Metabolic Disorders
2.4.5 Cerebrovascular Disorders
2.5 EEG, EMG and Evoked Potential Devices Sales by Application
2.5.1 Global EEG, EMG and Evoked Potential Devices Sale Market Share by Application (2018-2023)
2.5.2 Global EEG, EMG and Evoked Potential Devices Revenue and Market Share by Application (2018-2023)
2.5.3 Global EEG, EMG and Evoked Potential Devices Sale Price by Application (2018-2023)
3 Global EEG, EMG and Evoked Potential Devices by Company
3.1 Global EEG, EMG and Evoked Potential Devices Breakdown Data by Company
3.1.1 Global EEG, EMG and Evoked Potential Devices Annual Sales by Company (2018-2023)
3.1.2 Global EEG, EMG and Evoked Potential Devices Sales Market Share by Company (2018-2023)
3.2 Global EEG, EMG and Evoked Potential Devices Annual Revenue by Company (2018-2023)
3.2.1 Global EEG, EMG and Evoked Potential Devices Revenue by Company (2018-2023)
3.2.2 Global EEG, EMG and Evoked Potential Devices Revenue Market Share by Company (2018-2023)
3.3 Global EEG, EMG and Evoked Potential Devices Sale Price by Company
3.4 Key Manufacturers EEG, EMG and Evoked Potential Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers EEG, EMG and Evoked Potential Devices Product Location Distribution
3.4.2 Players EEG, EMG and Evoked Potential Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for EEG, EMG and Evoked Potential Devices by Geographic Region
4.1 World Historic EEG, EMG and Evoked Potential Devices Market Size by Geographic Region (2018-2023)
4.1.1 Global EEG, EMG and Evoked Potential Devices Annual Sales by Geographic Region (2018-2023)
4.1.2 Global EEG, EMG and Evoked Potential Devices Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic EEG, EMG and Evoked Potential Devices Market Size by Country/Region (2018-2023)
4.2.1 Global EEG, EMG and Evoked Potential Devices Annual Sales by Country/Region (2018-2023)
4.2.2 Global EEG, EMG and Evoked Potential Devices Annual Revenue by Country/Region (2018-2023)
4.3 Americas EEG, EMG and Evoked Potential Devices Sales Growth
4.4 APAC EEG, EMG and Evoked Potential Devices Sales Growth
4.5 Europe EEG, EMG and Evoked Potential Devices Sales Growth
4.6 Middle East & Africa EEG, EMG and Evoked Potential Devices Sales Growth
5 Americas
5.1 Americas EEG, EMG and Evoked Potential Devices Sales by Country
5.1.1 Americas EEG, EMG and Evoked Potential Devices Sales by Country (2018-2023)
5.1.2 Americas EEG, EMG and Evoked Potential Devices Revenue by Country (2018-2023)
5.2 Americas EEG, EMG and Evoked Potential Devices Sales by Type
5.3 Americas EEG, EMG and Evoked Potential Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC EEG, EMG and Evoked Potential Devices Sales by Region
6.1.1 APAC EEG, EMG and Evoked Potential Devices Sales by Region (2018-2023)
6.1.2 APAC EEG, EMG and Evoked Potential Devices Revenue by Region (2018-2023)
6.2 APAC EEG, EMG and Evoked Potential Devices Sales by Type
6.3 APAC EEG, EMG and Evoked Potential Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe EEG, EMG and Evoked Potential Devices by Country
7.1.1 Europe EEG, EMG and Evoked Potential Devices Sales by Country (2018-2023)
7.1.2 Europe EEG, EMG and Evoked Potential Devices Revenue by Country (2018-2023)
7.2 Europe EEG, EMG and Evoked Potential Devices Sales by Type
7.3 Europe EEG, EMG and Evoked Potential Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa EEG, EMG and Evoked Potential Devices by Country
8.1.1 Middle East & Africa EEG, EMG and Evoked Potential Devices Sales by Country (2018-2023)
8.1.2 Middle East & Africa EEG, EMG and Evoked Potential Devices Revenue by Country (2018-2023)
8.2 Middle East & Africa EEG, EMG and Evoked Potential Devices Sales by Type
8.3 Middle East & Africa EEG, EMG and Evoked Potential Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of EEG, EMG and Evoked Potential Devices
10.3 Manufacturing Process Analysis of EEG, EMG and Evoked Potential Devices
10.4 Industry Chain Structure of EEG, EMG and Evoked Potential Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 EEG, EMG and Evoked Potential Devices Distributors
11.3 EEG, EMG and Evoked Potential Devices Customer
12 World Forecast Review for EEG, EMG and Evoked Potential Devices by Geographic Region
12.1 Global EEG, EMG and Evoked Potential Devices Market Size Forecast by Region
12.1.1 Global EEG, EMG and Evoked Potential Devices Forecast by Region (2024-2029)
12.1.2 Global EEG, EMG and Evoked Potential Devices Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global EEG, EMG and Evoked Potential Devices Forecast by Type
12.7 Global EEG, EMG and Evoked Potential Devices Forecast by Application
13 Key Players Analysis
13.1 Cadwell Laboratories(US)
13.1.1 Cadwell Laboratories(US) Company Information
13.1.2 Cadwell Laboratories(US) EEG, EMG and Evoked Potential Devices Product Portfolios and Specifications
13.1.3 Cadwell Laboratories(US) EEG, EMG and Evoked Potential Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Cadwell Laboratories(US) Main Business Overview
13.1.5 Cadwell Laboratories(US) Latest Developments
13.2 Compumedics Limited (Australia)
13.2.1 Compumedics Limited (Australia) Company Information
13.2.2 Compumedics Limited (Australia) EEG, EMG and Evoked Potential Devices Product Portfolios and Specifications
13.2.3 Compumedics Limited (Australia) EEG, EMG and Evoked Potential Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Compumedics Limited (Australia) Main Business Overview
13.2.5 Compumedics Limited (Australia) Latest Developments
13.3 EB Neuro S.P.A. (Italy)
13.3.1 EB Neuro S.P.A. (Italy) Company Information
13.3.2 EB Neuro S.P.A. (Italy) EEG, EMG and Evoked Potential Devices Product Portfolios and Specifications
13.3.3 EB Neuro S.P.A. (Italy) EEG, EMG and Evoked Potential Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 EB Neuro S.P.A. (Italy) Main Business Overview
13.3.5 EB Neuro S.P.A. (Italy) Latest Developments
13.4 Electrical Geodesics(US)
13.4.1 Electrical Geodesics(US) Company Information
13.4.2 Electrical Geodesics(US) EEG, EMG and Evoked Potential Devices Product Portfolios and Specifications
13.4.3 Electrical Geodesics(US) EEG, EMG and Evoked Potential Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Electrical Geodesics(US) Main Business Overview
13.4.5 Electrical Geodesics(US) Latest Developments
13.5 Lifelines Neurodiagnostic Systems(US)
13.5.1 Lifelines Neurodiagnostic Systems(US) Company Information
13.5.2 Lifelines Neurodiagnostic Systems(US) EEG, EMG and Evoked Potential Devices Product Portfolios and Specifications
13.5.3 Lifelines Neurodiagnostic Systems(US) EEG, EMG and Evoked Potential Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Lifelines Neurodiagnostic Systems(US) Main Business Overview
13.5.5 Lifelines Neurodiagnostic Systems(US) Latest Developments
13.6 Natus Medical Incorporated (US)
13.6.1 Natus Medical Incorporated (US) Company Information
13.6.2 Natus Medical Incorporated (US) EEG, EMG and Evoked Potential Devices Product Portfolios and Specifications
13.6.3 Natus Medical Incorporated (US) EEG, EMG and Evoked Potential Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Natus Medical Incorporated (US) Main Business Overview
13.6.5 Natus Medical Incorporated (US) Latest Developments
13.7 NeuroWave Systems(US)
13.7.1 NeuroWave Systems(US) Company Information
13.7.2 NeuroWave Systems(US) EEG, EMG and Evoked Potential Devices Product Portfolios and Specifications
13.7.3 NeuroWave Systems(US) EEG, EMG and Evoked Potential Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 NeuroWave Systems(US) Main Business Overview
13.7.5 NeuroWave Systems(US) Latest Developments
13.8 Nihon Kohden Corporation (Japan)
13.8.1 Nihon Kohden Corporation (Japan) Company Information
13.8.2 Nihon Kohden Corporation (Japan) EEG, EMG and Evoked Potential Devices Product Portfolios and Specifications
13.8.3 Nihon Kohden Corporation (Japan) EEG, EMG and Evoked Potential Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Nihon Kohden Corporation (Japan) Main Business Overview
13.8.5 Nihon Kohden Corporation (Japan) Latest Developments
13.9 Nihon Kohden America(US)
13.9.1 Nihon Kohden America(US) Company Information
13.9.2 Nihon Kohden America(US) EEG, EMG and Evoked Potential Devices Product Portfolios and Specifications
13.9.3 Nihon Kohden America(US) EEG, EMG and Evoked Potential Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Nihon Kohden America(US) Main Business Overview
13.9.5 Nihon Kohden America(US) Latest Developments
13.10 Noraxon USA.(US)
13.10.1 Noraxon USA.(US) Company Information
13.10.2 Noraxon USA.(US) EEG, EMG and Evoked Potential Devices Product Portfolios and Specifications
13.10.3 Noraxon USA.(US) EEG, EMG and Evoked Potential Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Noraxon USA.(US) Main Business Overview
13.10.5 Noraxon USA.(US) Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. EEG, EMG and Evoked Potential Devices Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. EEG, EMG and Evoked Potential Devices Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Electroencephalography (EEG)
Table 4. Major Players of Electromyography (EMG)
Table 5. Major Players of Evoked Potential
Table 6. Global EEG, EMG and Evoked Potential Devices Sales by Type (2018-2023) & (K Units)
Table 7. Global EEG, EMG and Evoked Potential Devices Sales Market Share by Type (2018-2023)
Table 8. Global EEG, EMG and Evoked Potential Devices Revenue by Type (2018-2023) & ($ million)
Table 9. Global EEG, EMG and Evoked Potential Devices Revenue Market Share by Type (2018-2023)
Table 10. Global EEG, EMG and Evoked Potential Devices Sale Price by Type (2018-2023) & (USD/Unit)
Table 11. Global EEG, EMG and Evoked Potential Devices Sales by Application (2018-2023) & (K Units)
Table 12. Global EEG, EMG and Evoked Potential Devices Sales Market Share by Application (2018-2023)
Table 13. Global EEG, EMG and Evoked Potential Devices Revenue by Application (2018-2023)
Table 14. Global EEG, EMG and Evoked Potential Devices Revenue Market Share by Application (2018-2023)
Table 15. Global EEG, EMG and Evoked Potential Devices Sale Price by Application (2018-2023) & (USD/Unit)
Table 16. Global EEG, EMG and Evoked Potential Devices Sales by Company (2018-2023) & (K Units)
Table 17. Global EEG, EMG and Evoked Potential Devices Sales Market Share by Company (2018-2023)
Table 18. Global EEG, EMG and Evoked Potential Devices Revenue by Company (2018-2023) ($ Millions)
Table 19. Global EEG, EMG and Evoked Potential Devices Revenue Market Share by Company (2018-2023)
Table 20. Global EEG, EMG and Evoked Potential Devices Sale Price by Company (2018-2023) & (USD/Unit)
Table 21. Key Manufacturers EEG, EMG and Evoked Potential Devices Producing Area Distribution and Sales Area
Table 22. Players EEG, EMG and Evoked Potential Devices Products Offered
Table 23. EEG, EMG and Evoked Potential Devices Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global EEG, EMG and Evoked Potential Devices Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global EEG, EMG and Evoked Potential Devices Sales Market Share Geographic Region (2018-2023)
Table 28. Global EEG, EMG and Evoked Potential Devices Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global EEG, EMG and Evoked Potential Devices Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global EEG, EMG and Evoked Potential Devices Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global EEG, EMG and Evoked Potential Devices Sales Market Share by Country/Region (2018-2023)
Table 32. Global EEG, EMG and Evoked Potential Devices Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global EEG, EMG and Evoked Potential Devices Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas EEG, EMG and Evoked Potential Devices Sales by Country (2018-2023) & (K Units)
Table 35. Americas EEG, EMG and Evoked Potential Devices Sales Market Share by Country (2018-2023)
Table 36. Americas EEG, EMG and Evoked Potential Devices Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas EEG, EMG and Evoked Potential Devices Revenue Market Share by Country (2018-2023)
Table 38. Americas EEG, EMG and Evoked Potential Devices Sales by Type (2018-2023) & (K Units)
Table 39. Americas EEG, EMG and Evoked Potential Devices Sales by Application (2018-2023) & (K Units)
Table 40. APAC EEG, EMG and Evoked Potential Devices Sales by Region (2018-2023) & (K Units)
Table 41. APAC EEG, EMG and Evoked Potential Devices Sales Market Share by Region (2018-2023)
Table 42. APAC EEG, EMG and Evoked Potential Devices Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC EEG, EMG and Evoked Potential Devices Revenue Market Share by Region (2018-2023)
Table 44. APAC EEG, EMG and Evoked Potential Devices Sales by Type (2018-2023) & (K Units)
Table 45. APAC EEG, EMG and Evoked Potential Devices Sales by Application (2018-2023) & (K Units)
Table 46. Europe EEG, EMG and Evoked Potential Devices Sales by Country (2018-2023) & (K Units)
Table 47. Europe EEG, EMG and Evoked Potential Devices Sales Market Share by Country (2018-2023)
Table 48. Europe EEG, EMG and Evoked Potential Devices Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe EEG, EMG and Evoked Potential Devices Revenue Market Share by Country (2018-2023)
Table 50. Europe EEG, EMG and Evoked Potential Devices Sales by Type (2018-2023) & (K Units)
Table 51. Europe EEG, EMG and Evoked Potential Devices Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa EEG, EMG and Evoked Potential Devices Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa EEG, EMG and Evoked Potential Devices Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa EEG, EMG and Evoked Potential Devices Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa EEG, EMG and Evoked Potential Devices Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa EEG, EMG and Evoked Potential Devices Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa EEG, EMG and Evoked Potential Devices Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of EEG, EMG and Evoked Potential Devices
Table 59. Key Market Challenges & Risks of EEG, EMG and Evoked Potential Devices
Table 60. Key Industry Trends of EEG, EMG and Evoked Potential Devices
Table 61. EEG, EMG and Evoked Potential Devices Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. EEG, EMG and Evoked Potential Devices Distributors List
Table 64. EEG, EMG and Evoked Potential Devices Customer List
Table 65. Global EEG, EMG and Evoked Potential Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global EEG, EMG and Evoked Potential Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas EEG, EMG and Evoked Potential Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas EEG, EMG and Evoked Potential Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC EEG, EMG and Evoked Potential Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC EEG, EMG and Evoked Potential Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe EEG, EMG and Evoked Potential Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe EEG, EMG and Evoked Potential Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa EEG, EMG and Evoked Potential Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa EEG, EMG and Evoked Potential Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global EEG, EMG and Evoked Potential Devices Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global EEG, EMG and Evoked Potential Devices Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global EEG, EMG and Evoked Potential Devices Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global EEG, EMG and Evoked Potential Devices Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Cadwell Laboratories(US) Basic Information, EEG, EMG and Evoked Potential Devices Manufacturing Base, Sales Area and Its Competitors
Table 80. Cadwell Laboratories(US) EEG, EMG and Evoked Potential Devices Product Portfolios and Specifications
Table 81. Cadwell Laboratories(US) EEG, EMG and Evoked Potential Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Cadwell Laboratories(US) Main Business
Table 83. Cadwell Laboratories(US) Latest Developments
Table 84. Compumedics Limited (Australia) Basic Information, EEG, EMG and Evoked Potential Devices Manufacturing Base, Sales Area and Its Competitors
Table 85. Compumedics Limited (Australia) EEG, EMG and Evoked Potential Devices Product Portfolios and Specifications
Table 86. Compumedics Limited (Australia) EEG, EMG and Evoked Potential Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Compumedics Limited (Australia) Main Business
Table 88. Compumedics Limited (Australia) Latest Developments
Table 89. EB Neuro S.P.A. (Italy) Basic Information, EEG, EMG and Evoked Potential Devices Manufacturing Base, Sales Area and Its Competitors
Table 90. EB Neuro S.P.A. (Italy) EEG, EMG and Evoked Potential Devices Product Portfolios and Specifications
Table 91. EB Neuro S.P.A. (Italy) EEG, EMG and Evoked Potential Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. EB Neuro S.P.A. (Italy) Main Business
Table 93. EB Neuro S.P.A. (Italy) Latest Developments
Table 94. Electrical Geodesics(US) Basic Information, EEG, EMG and Evoked Potential Devices Manufacturing Base, Sales Area and Its Competitors
Table 95. Electrical Geodesics(US) EEG, EMG and Evoked Potential Devices Product Portfolios and Specifications
Table 96. Electrical Geodesics(US) EEG, EMG and Evoked Potential Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Electrical Geodesics(US) Main Business
Table 98. Electrical Geodesics(US) Latest Developments
Table 99. Lifelines Neurodiagnostic Systems(US) Basic Information, EEG, EMG and Evoked Potential Devices Manufacturing Base, Sales Area and Its Competitors
Table 100. Lifelines Neurodiagnostic Systems(US) EEG, EMG and Evoked Potential Devices Product Portfolios and Specifications
Table 101. Lifelines Neurodiagnostic Systems(US) EEG, EMG and Evoked Potential Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. Lifelines Neurodiagnostic Systems(US) Main Business
Table 103. Lifelines Neurodiagnostic Systems(US) Latest Developments
Table 104. Natus Medical Incorporated (US) Basic Information, EEG, EMG and Evoked Potential Devices Manufacturing Base, Sales Area and Its Competitors
Table 105. Natus Medical Incorporated (US) EEG, EMG and Evoked Potential Devices Product Portfolios and Specifications
Table 106. Natus Medical Incorporated (US) EEG, EMG and Evoked Potential Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Natus Medical Incorporated (US) Main Business
Table 108. Natus Medical Incorporated (US) Latest Developments
Table 109. NeuroWave Systems(US) Basic Information, EEG, EMG and Evoked Potential Devices Manufacturing Base, Sales Area and Its Competitors
Table 110. NeuroWave Systems(US) EEG, EMG and Evoked Potential Devices Product Portfolios and Specifications
Table 111. NeuroWave Systems(US) EEG, EMG and Evoked Potential Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. NeuroWave Systems(US) Main Business
Table 113. NeuroWave Systems(US) Latest Developments
Table 114. Nihon Kohden Corporation (Japan) Basic Information, EEG, EMG and Evoked Potential Devices Manufacturing Base, Sales Area and Its Competitors
Table 115. Nihon Kohden Corporation (Japan) EEG, EMG and Evoked Potential Devices Product Portfolios and Specifications
Table 116. Nihon Kohden Corporation (Japan) EEG, EMG and Evoked Potential Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Nihon Kohden Corporation (Japan) Main Business
Table 118. Nihon Kohden Corporation (Japan) Latest Developments
Table 119. Nihon Kohden America(US) Basic Information, EEG, EMG and Evoked Potential Devices Manufacturing Base, Sales Area and Its Competitors
Table 120. Nihon Kohden America(US) EEG, EMG and Evoked Potential Devices Product Portfolios and Specifications
Table 121. Nihon Kohden America(US) EEG, EMG and Evoked Potential Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Nihon Kohden America(US) Main Business
Table 123. Nihon Kohden America(US) Latest Developments
Table 124. Noraxon USA.(US) Basic Information, EEG, EMG and Evoked Potential Devices Manufacturing Base, Sales Area and Its Competitors
Table 125. Noraxon USA.(US) EEG, EMG and Evoked Potential Devices Product Portfolios and Specifications
Table 126. Noraxon USA.(US) EEG, EMG and Evoked Potential Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. Noraxon USA.(US) Main Business
Table 128. Noraxon USA.(US) Latest Developments
List of Figures
Figure 1. Picture of EEG, EMG and Evoked Potential Devices
Figure 2. EEG, EMG and Evoked Potential Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global EEG, EMG and Evoked Potential Devices Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global EEG, EMG and Evoked Potential Devices Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. EEG, EMG and Evoked Potential Devices Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Electroencephalography (EEG)
Figure 10. Product Picture of Electromyography (EMG)
Figure 11. Product Picture of Evoked Potential
Figure 12. Global EEG, EMG and Evoked Potential Devices Sales Market Share by Type in 2022
Figure 13. Global EEG, EMG and Evoked Potential Devices Revenue Market Share by Type (2018-2023)
Figure 14. EEG, EMG and Evoked Potential Devices Consumed in Infections
Figure 15. Global EEG, EMG and Evoked Potential Devices Market: Infections (2018-2023) & (K Units)
Figure 16. EEG, EMG and Evoked Potential Devices Consumed in Head Injuries
Figure 17. Global EEG, EMG and Evoked Potential Devices Market: Head Injuries (2018-2023) & (K Units)
Figure 18. EEG, EMG and Evoked Potential Devices Consumed in Coma and Brain Death
Figure 19. Global EEG, EMG and Evoked Potential Devices Market: Coma and Brain Death (2018-2023) & (K Units)
Figure 20. EEG, EMG and Evoked Potential Devices Consumed in Metabolic Disorders
Figure 21. Global EEG, EMG and Evoked Potential Devices Market: Metabolic Disorders (2018-2023) & (K Units)
Figure 22. EEG, EMG and Evoked Potential Devices Consumed in Cerebrovascular Disorders
Figure 23. Global EEG, EMG and Evoked Potential Devices Market: Cerebrovascular Disorders (2018-2023) & (K Units)
Figure 24. Global EEG, EMG and Evoked Potential Devices Sales Market Share by Application (2022)
Figure 25. Global EEG, EMG and Evoked Potential Devices Revenue Market Share by Application in 2022
Figure 26. EEG, EMG and Evoked Potential Devices Sales Market by Company in 2022 (K Units)
Figure 27. Global EEG, EMG and Evoked Potential Devices Sales Market Share by Company in 2022
Figure 28. EEG, EMG and Evoked Potential Devices Revenue Market by Company in 2022 ($ Million)
Figure 29. Global EEG, EMG and Evoked Potential Devices Revenue Market Share by Company in 2022
Figure 30. Global EEG, EMG and Evoked Potential Devices Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global EEG, EMG and Evoked Potential Devices Revenue Market Share by Geographic Region in 2022
Figure 32. Americas EEG, EMG and Evoked Potential Devices Sales 2018-2023 (K Units)
Figure 33. Americas EEG, EMG and Evoked Potential Devices Revenue 2018-2023 ($ Millions)
Figure 34. APAC EEG, EMG and Evoked Potential Devices Sales 2018-2023 (K Units)
Figure 35. APAC EEG, EMG and Evoked Potential Devices Revenue 2018-2023 ($ Millions)
Figure 36. Europe EEG, EMG and Evoked Potential Devices Sales 2018-2023 (K Units)
Figure 37. Europe EEG, EMG and Evoked Potential Devices Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa EEG, EMG and Evoked Potential Devices Sales 2018-2023 (K Units)
Figure 39. Middle East & Africa EEG, EMG and Evoked Potential Devices Revenue 2018-2023 ($ Millions)
Figure 40. Americas EEG, EMG and Evoked Potential Devices Sales Market Share by Country in 2022
Figure 41. Americas EEG, EMG and Evoked Potential Devices Revenue Market Share by Country in 2022
Figure 42. Americas EEG, EMG and Evoked Potential Devices Sales Market Share by Type (2018-2023)
Figure 43. Americas EEG, EMG and Evoked Potential Devices Sales Market Share by Application (2018-2023)
Figure 44. United States EEG, EMG and Evoked Potential Devices Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada EEG, EMG and Evoked Potential Devices Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico EEG, EMG and Evoked Potential Devices Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil EEG, EMG and Evoked Potential Devices Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC EEG, EMG and Evoked Potential Devices Sales Market Share by Region in 2022
Figure 49. APAC EEG, EMG and Evoked Potential Devices Revenue Market Share by Regions in 2022
Figure 50. APAC EEG, EMG and Evoked Potential Devices Sales Market Share by Type (2018-2023)
Figure 51. APAC EEG, EMG and Evoked Potential Devices Sales Market Share by Application (2018-2023)
Figure 52. China EEG, EMG and Evoked Potential Devices Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan EEG, EMG and Evoked Potential Devices Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea EEG, EMG and Evoked Potential Devices Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia EEG, EMG and Evoked Potential Devices Revenue Growth 2018-2023 ($ Millions)
Figure 56. India EEG, EMG and Evoked Potential Devices Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia EEG, EMG and Evoked Potential Devices Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan EEG, EMG and Evoked Potential Devices Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe EEG, EMG and Evoked Potential Devices Sales Market Share by Country in 2022
Figure 60. Europe EEG, EMG and Evoked Potential Devices Revenue Market Share by Country in 2022
Figure 61. Europe EEG, EMG and Evoked Potential Devices Sales Market Share by Type (2018-2023)
Figure 62. Europe EEG, EMG and Evoked Potential Devices Sales Market Share by Application (2018-2023)
Figure 63. Germany EEG, EMG and Evoked Potential Devices Revenue Growth 2018-2023 ($ Millions)
Figure 64. France EEG, EMG and Evoked Potential Devices Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK EEG, EMG and Evoked Potential Devices Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy EEG, EMG and Evoked Potential Devices Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia EEG, EMG and Evoked Potential Devices Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa EEG, EMG and Evoked Potential Devices Sales Market Share by Country in 2022
Figure 69. Middle East & Africa EEG, EMG and Evoked Potential Devices Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa EEG, EMG and Evoked Potential Devices Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa EEG, EMG and Evoked Potential Devices Sales Market Share by Application (2018-2023)
Figure 72. Egypt EEG, EMG and Evoked Potential Devices Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa EEG, EMG and Evoked Potential Devices Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel EEG, EMG and Evoked Potential Devices Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey EEG, EMG and Evoked Potential Devices Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country EEG, EMG and Evoked Potential Devices Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of EEG, EMG and Evoked Potential Devices in 2022
Figure 78. Manufacturing Process Analysis of EEG, EMG and Evoked Potential Devices
Figure 79. Industry Chain Structure of EEG, EMG and Evoked Potential Devices
Figure 80. Channels of Distribution
Figure 81. Global EEG, EMG and Evoked Potential Devices Sales Market Forecast by Region (2024-2029)
Figure 82. Global EEG, EMG and Evoked Potential Devices Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global EEG, EMG and Evoked Potential Devices Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global EEG, EMG and Evoked Potential Devices Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global EEG, EMG and Evoked Potential Devices Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global EEG, EMG and Evoked Potential Devices Revenue Market Share Forecast by Application (2024-2029)

※参考情報

EEG（脳波）、EMG（筋電図）、誘発電位検査装置は、神経生理学的な検査手法を用いて、脳や神経、筋肉の機能を評価するための重要な医療機器です。これらの装置は、神経系の異常を検出し診断するための有用な情報を提供します。

EEGは、脳波を記録するための装置であり、脳内の電気的活動を測定します。脳は神経細胞の集まりで構成され、これらの細胞が発生させる電気信号が脳波として外部に表れます。EEG検査は、通常、頭皮に配置された複数の電極を用いて行われ、数分から数時間の間、脳波の変化を観察します。EEGは、てんかんや睡眠障害、脳損傷の評価など、多くの神経疾患の診断に役立ちます。

一方、EMGは、筋肉の電気的活動を測定するための装置です。筋電図は、神経が筋肉をどのように制御しているかを評価するために使用され、神経や筋肉の病変を特定する手助けをします。EMGでは、針電極または表面電極を使用し、筋肉の活動を記録します。これにより、筋萎縮症や神経障害などの病状を診断することができます。さらに、EMGは、手術前後の筋肉機能の評価やリハビリテーション計画にも活用されます。

誘発電位検査は、特定の感覚刺激に対する神経系の応答を評価するための方法です。たとえば、視覚誘発電位や聴覚誘発電位などがあり、外部からの刺激によって神経伝導の特性を測定します。この検査は、視神経や聴神経に関連する病状の診断、特に多発性硬化症や神経障害の評価に重要です。誘発電位検査では、通常、電極を頭皮や体の特定の部位に配置し、刺激を与えた後の電位変化を記録します。

これらの検査装置は、それぞれ異なる特長を持ち、神経系の異常を詳細に解析するための方法が提供されます。EEGは、脳波の連続的なモニタリングが可能であり、特に発作や異常活動の瞬間を捉えるのに効果的です。EMGは、筋肉の状態をリアルタイムで評価でき、特に運動機能の障害を詳細に調べることができます。誘発電位検査は、視覚や聴覚などの特定の感覚経路を評価できるため、神経伝導の効率を測る上で重要です。

これらの技術は、互いに補完し合いながら、より包括的な神経生理学的な評価を可能にします。例えば、てんかん患者に対してEEGによる脳波の解析を行い、さらにEMGを利用して筋肉の活動を調査し、最後に誘発電位検査を通じて感覚神経の伝導性を確認することで、総合的な神経評価が行えます。このように、神経系の診断においては多角的なアプローチが求められるのです。

最近では、これらの技術に関連した新たなアプローチも見られます。例えば、EEGやEMGのデータを機械学習や人工知能技術を用いて解析する試みが進められています。これにより、膨大なデータからパターンを抽出し、異常検知の精度を向上させることが期待されています。特に、AIによる解析は、診断の迅速化や精度向上に寄与する可能性があります。

また、ポータブルなEEG装置やEMG装置の開発が進んでおり、患者が日常生活を送りながらモニタリングを行うことが可能となっています。これにより、従来の病院での静止状態での検査に代わり、より自然な条件下でのデータ収集が行えるようになっています。これにより、生活の質を維持しながら、より正確なデータを取得できるようになっています。

さらに、これらの技術の進展は、神経リハビリテーションや脳-機械インターフェースの領域にも広がっています。たとえば、EMG信号を利用した義肢の制御や、EEGによる脳波を使ったコミュニケーション手段の開発が進んでおり、神経疾患や運動機能の障害を抱える患者に対して、新しい治療法や補助具が提供されています。これらの技術は、徐々に医療現場において重要な役割を果たすようになってきています。

総じて、EEG、EMG、誘発電位検査装置は、神経系の機能を評価するための重要なツールであると言えます。それぞれ異なる視点から神経生理学的な情報を提供し、さまざまな神経疾患の診断や治療に寄与しています。今後もさらなる技術の進展により、これらの装置の精度や効率は向上し、より多くの患者に対して新たな治療の道を開くことが期待されます。これらの技術の普及と発展は、神経医学の進歩にとって非常に重要な要素となることでしょう。


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ EEG/EMG/誘発電位検査装置のグローバル市場予測2023-2029(Global EEG, EMG and Evoked Potential Devices Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • てんかん監視装置のグローバル市場予測2023-2029
  • EEG＆EMG装置のグローバル市場予測2023-2029
  • 心電図装置のグローバル市場予測2023-2029
  • 外傷性脳損傷評価＆管理装置のグローバル市場予測2023-2029
  • ECGテレメトリー式装置のグローバル市場予測2023-2029

    • ◆H&Iグローバルリサーチのお客様（例）◆